Literature DB >> 18794728

Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes.

Tatsuki Fukami1, Miki Nakajima, Taiga Maruichi, Shiori Takahashi, Masataka Takamiya, Yasuhiro Aoki, Howard L McLeod, Tsuyoshi Yokoi.   

Abstract

OBJECTIVE: Human carboxylesterase (CES) 1A1 gene (14 exons) and CES1A3 pseudogene (six exons) are inverted and duplicated genes in a reference sequence (NT_010498). In contrast, earlier studies reported the CES1A2 gene (14 exons) instead of the CES1A3 pseudogene. The sequences of the CES1A2 gene downstream and upstream of intron 1 are identical with those of the CES1A1 and CES1A3 genes, respectively. A CES1A1 variant of which exon 1 is converted with that of the CES1A3 gene (the transcript is CES1A2) has recently been identified. We sought to clarify the confusing gene structure of human CES1A.
METHODS: A panel of 55 human liver as well as 318 blood samples (104 Caucasians, 107 African-Americans, and 107 Japanese) was used to clarify the gene structures of CES1A1, CES1A2, and CES1A3. Real-time reverse transcription-PCR and western blot analysis were carried out. Imidapril hydrolase activity in human liver microsomes and cytosol was determined by liquid chromatography-mass spectrometry (LC-MS)/MS.
RESULTS: By PCR analyses, we found that the CES1A2 gene is a variant of the CES1A3 gene. Four haplotypes, A (CES1A1 wild type and CES1A3), B (CES1A1 wild type and CES1A2), C (CES1A1 variant and CES1A3), and D (CES1A1 variant and CES1A2), were demonstrated. Ethnic differences were observed in allele frequencies of CES1A1 variant (17.3% in Caucasians and African-Americans and 25.2% in Japanese) and CES1A2 gene (14.4% in Caucasians, 5.1% in African-Americans, and 31.3% in Japanese). In human livers whose diplotype was A/A and C/C or C/D, no CES1A2 and CES1A1 mRNA was detected, respectively. In the other participants, the CES1A1 mRNA levels were higher than the CES1A2 mRNA levels. The CES1A proteins translated from CES1A1 mRNA and CES1A2 mRNA were detected in both human liver microsomes and cytosol fractions suggesting that the differences in exon 1 encoding a signal peptide did not affect the subcellular localization. Imidapril hydrolase activities reflected the CES1A protein levels.
CONCLUSION: We found that the CES1A2 gene is a variant of the CES1A3 pseudogene. The findings presented here significantly increase our understanding about the gene structure and expression properties of human CES1A.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794728     DOI: 10.1097/FPC.0b013e32830b0c5e

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  27 in total

1.  The impact of CES1 genotypes on the pharmacokinetics of methylphenidate in healthy Danish subjects.

Authors:  Claus Stage; Gesche Jürgens; Louise Schow Guski; Ragnar Thomsen; Ditte Bjerre; Laura Ferrero-Miliani; Yassine Kamal Lyauk; Henrik Berg Rasmussen; Kim Dalhoff
Journal:  Br J Clin Pharmacol       Date:  2017-02-24       Impact factor: 4.335

2.  CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.

Authors:  Hao-Jie Zhu; Taimour Y Langaee; Yan Gong; Xinwen Wang; Carl J Pepine; Rhonda M Cooper-DeHoff; Julie A Johnson; John S Markowitz
Journal:  Eur J Clin Pharmacol       Date:  2016-02-26       Impact factor: 2.953

Review 3.  Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.

Authors:  Lucy Her; Hao-Jie Zhu
Journal:  Drug Metab Dispos       Date:  2019-12-23       Impact factor: 3.922

4.  Multicolor imaging of endoplasmic reticulum-located esterase as a prodrug activation enzyme.

Authors:  Wataru Hakamata; Saori Tamura; Takako Hirano; Toshiyuki Nishio
Journal:  ACS Med Chem Lett       Date:  2014-01-16       Impact factor: 4.345

5.  Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump.

Authors:  Dongfang Yang; Jian Yang; Deshi Shi; Da Xiao; Yi-Tzai Chen; Chris Black; Ruitang Deng; Bingfang Yan
Journal:  J Lipid Res       Date:  2012-01-14       Impact factor: 5.922

Review 6.  Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.

Authors:  Tamorah R Lewis; Elaine L Shelton; Sara L Van Driest; Prince J Kannankeril; Jeff Reese
Journal:  Semin Fetal Neonatal Med       Date:  2018-02-24       Impact factor: 3.926

7.  Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression.

Authors:  Roman Tremmel; Kathrin Klein; Florian Battke; Sarah Fehr; Stefan Winter; Tim Scheurenbrand; Elke Schaeffeler; Saskia Biskup; Matthias Schwab; Ulrich M Zanger
Journal:  Hum Genet       Date:  2019-11-30       Impact factor: 4.132

8.  Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus.

Authors:  Jonathan C Sanford; Xinwen Wang; Jian Shi; Elizabeth S Barrie; Danxin Wang; Hao-Jie Zhu; Wolfgang Sadee
Journal:  Pharmacogenet Genomics       Date:  2016-05       Impact factor: 2.089

9.  Human α/β hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liver.

Authors:  Atsushi Iwamura; Tatsuki Fukami; Ryota Higuchi; Miki Nakajima; Tsuyoshi Yokoi
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

10.  Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation.

Authors:  Hao-Jie Zhu; John S Markowitz
Journal:  Eur J Clin Pharmacol       Date:  2012-07-31       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.